These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 30211779)

  • 1. Brief Report: The Anti-HIV-1 ADCC-Mediating Antibodies From Cervicovaginal Secretions of HIV-Infected Women Have an Ability to Mediate Lysing of Autologous CD4+ HIV-Infected Cells.
    Dhande J; Angadi M; Murugavel KG; Poongulali S; Nandagopal P; Vignesh R; Ghate M; Kulkarni S; Thakar M
    J Acquir Immune Defic Syndr; 2018 Oct; 79(2):277-282. PubMed ID: 30211779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women with cervicovaginal antibody-dependent cell-mediated cytotoxicity have lower genital HIV-1 RNA loads.
    Nag P; Kim J; Sapiega V; Landay AL; Bremer JW; Mestecky J; Reichelderfer P; Kovacs A; Cohn J; Weiser B; Baum LL
    J Infect Dis; 2004 Dec; 190(11):1970-8. PubMed ID: 15529262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding.
    Smalls-Mantey A; Doria-Rose N; Klein R; Patamawenu A; Migueles SA; Ko SY; Hallahan CW; Wong H; Liu B; You L; Scheid J; Kappes JC; Ochsenbauer C; Nabel GJ; Mascola JR; Connors M
    J Virol; 2012 Aug; 86(16):8672-80. PubMed ID: 22674985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short communication: Anti-HIV-1 envelope immunoglobulin Gs in blood and cervicovaginal samples of Beninese commercial sex workers.
    Batraville LA; Richard J; Veillette M; Labbé AC; Alary M; Guédou F; Kaufmann DE; Poudrier J; Finzi A; Roger M
    AIDS Res Hum Retroviruses; 2014 Nov; 30(11):1145-9. PubMed ID: 25354025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-HIV-1 ADCC and HIV-1 Env Can Be Partners in Reducing Latent HIV Reservoir.
    Suryawanshi P; Bagul R; Shete A; Thakar M
    Front Immunol; 2021; 12():663919. PubMed ID: 33995393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120.
    Smith SA; Burton SL; Kilembe W; Lakhi S; Karita E; Price M; Allen S; Derdeyn CA
    Front Immunol; 2018; 9():3163. PubMed ID: 30697215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4- and Time-Dependent Susceptibility of HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity.
    Lee WS; Prévost J; Richard J; van der Sluis RM; Lewin SR; Pazgier M; Finzi A; Parsons MS; Kent SJ
    J Virol; 2019 May; 93(10):. PubMed ID: 30842324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 mimetics sensitize HIV-1-infected cells to ADCC.
    Richard J; Veillette M; Brassard N; Iyer SS; Roger M; Martin L; Pazgier M; Schön A; Freire E; Routy JP; Smith AB; Park J; Jones DM; Courter JR; Melillo BN; Kaufmann DE; Hahn BH; Permar SR; Haynes BF; Madani N; Sodroski JG; Finzi A
    Proc Natl Acad Sci U S A; 2015 May; 112(20):E2687-94. PubMed ID: 25941367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts.
    Madhavi V; Kulkarni A; Shete A; Lee WS; Mclean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ;
    J Acquir Immune Defic Syndr; 2017 Jul; 75(3):345-353. PubMed ID: 28346319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract.
    Sha BE; D'Amico RD; Landay AL; Spear GT; Massad LS; Rydman RJ; Warner NA; Padnick J; Ackatz L; Charles LA; Benson CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov; 16(3):161-8. PubMed ID: 9390567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-dependent cell-mediated cytotoxicity in cervical lavage fluids of human immunodeficiency virus type 1--infected women.
    Battle-Miller K; Eby CA; Landay AL; Cohen MH; Sha BE; Baum LL
    J Infect Dis; 2002 Feb; 185(4):439-47. PubMed ID: 11865395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression.
    Ojo-Amaize E; Nishanian PG; Heitjan DF; Rezai A; Esmail I; Korns E; Detels R; Fahey J; Giorgi JV
    J Clin Immunol; 1989 Nov; 9(6):454-61. PubMed ID: 2576558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
    Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
    PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between antibody-dependent cellular cytotoxicity, plasma HIV type 1 RNA, and CD4+ lymphocyte count.
    Forthal DN; Landucci G; Keenan B
    AIDS Res Hum Retroviruses; 2001 Apr; 17(6):553-61. PubMed ID: 11350669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
    Front Immunol; 2018; 9():244. PubMed ID: 29651286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NK cell function and antibodies mediating ADCC in HIV-1-infected viremic and controller patients.
    Johansson SE; Rollman E; Chung AW; Center RJ; Hejdeman B; Stratov I; Hinkula J; Wahren B; Kärre K; Kent SJ; Berg L
    Viral Immunol; 2011 Oct; 24(5):359-68. PubMed ID: 21958370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Baseline ADCC Responses in Chronic Nonprogressive HIV Infection Are Associated with Reduced HIV Burden in Later Course of Disease.
    Talathi S; Bagul R; Ghate M; Kulkarni S; Thakar M
    Viral Immunol; 2020 Mar; 33(2):77-85. PubMed ID: 31976826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.